Publications scientifiques

Nos publications scientifiques sur la validation de l'ACT pour le traitement de l'insomnie :

- Chapoutot M, Peter-Derex L, Schoendorff B, Faivre T, Bastuji H, Putois B. Telehealth-delivered CBT-I programme enhanced by acceptance and commitment therapy for insomnia and hypnotic dependence: A pilot randomized controlled trial. J Sleep Res. 2021 Feb;30(1):e13199. doi: 10.1111/jsr.13199. Epub 2020 Oct 5. PMID: 33020985.

- Chapoutot, Peter-Derex, Bastuji, Leslie, Schoendorff, Heinzer, Siclari, Nicolas, Lemoine, Higgins, Bourgeois, Vallet, Anders, Ounnoughene, Spencer, & Putois (2022). Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders. Int. J. Environ. Res. Public Health, 2021, 18, 10222. https://doi.org/10.3390/ijerph181910222

- Chapoutot, Peter-Derex, Bastuji, Leslie, Schoendorff, Heinzer, Siclari, Nicolas, Lemoine, Higgins, Bourgeois, Vallet, Anders, Ounnoughene, Spencer, Meloni, & Putois (soumission 2023). A narrative review of strategies for discontinuing long-term benzodiazepine use and methodological recommendations: can we say that withdrawal is effective if less than 1 in 2 patients become abstinent? x, x, x. 

Spencer, J.: Gustin, M. P.; Anders, R.; Chapoutot M. ; Leslie, W. ; Schoendorff, B. ; Francis, A. W. ; Dawson, D. L. ; Putois, B. (soumission 2023) French adaptation and psychometric validation of the Comprehensive Assessment of Acceptance and Commitment Therapy . x, x, x. 

Les autres publications scientifiques sur la validation de l'ACT pour le traitement de l'insomnie :

Cliquez ici.